These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 33440238)

  • 1. Metabolomics profiling reveals altered lipid metabolism and identifies a panel of lipid metabolites as biomarkers for Parkinson's disease related anxiety disorder.
    Dong MX; Hu L; Wei YD; Chen GH
    Neurosci Lett; 2021 Feb; 745():135626. PubMed ID: 33440238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid metabolic dysregulation is involved in Parkinson's disease dementia.
    Dong MX; Wei YD; Hu L
    Metab Brain Dis; 2021 Mar; 36(3):463-470. PubMed ID: 33433787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolomics of sebum reveals lipid dysregulation in Parkinson's disease.
    Sinclair E; Trivedi DK; Sarkar D; Walton-Doyle C; Milne J; Kunath T; Rijs AM; de Bie RMA; Goodacre R; Silverdale M; Barran P
    Nat Commun; 2021 Mar; 12(1):1592. PubMed ID: 33707447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profiling novel metabolic biomarkers for Parkinson's disease using in-depth metabolomic analysis.
    Han W; Sapkota S; Camicioli R; Dixon RA; Li L
    Mov Disord; 2017 Dec; 32(12):1720-1728. PubMed ID: 28880465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential biomarkers of Parkinson's disease revealed by plasma metabolic profiling.
    Zhao H; Wang C; Zhao N; Li W; Yang Z; Liu X; Le W; Zhang X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Apr; 1081-1082():101-108. PubMed ID: 29518718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The disturbance of lipid metabolism is correlated with neuropsychiatric symptoms in patients with Parkinson's disease.
    Dong MX; Wei YD; Hu L
    Chem Phys Lipids; 2021 Sep; 239():105112. PubMed ID: 34216587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated Analysis Reveals Altered Lipid and Glucose Metabolism and Identifies NOTCH2 as a Biomarker for Parkinson's Disease Related Depression.
    Dong MX; Feng X; Xu XM; Hu L; Liu Y; Jia SY; Li B; Chen W; Wei YD
    Front Mol Neurosci; 2018; 11():257. PubMed ID: 30233306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Performance Liquid Chromatography-Mass Spectrometry (LC-MS) Based Quantitative Lipidomics Study of Ganglioside-NANA-3 Plasma to Establish Its Association with Parkinson's Disease Patients.
    Zhang J; Zhang X; Wang L; Yang C
    Med Sci Monit; 2017 Nov; 23():5345-5353. PubMed ID: 29123078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolomics Profiling Discriminates Prostate Cancer From Benign Prostatic Hyperplasia Within the Prostate-Specific Antigen Gray Zone.
    Xu B; Chen Y; Chen X; Gan L; Zhang Y; Feng J; Yu L
    Front Oncol; 2021; 11():730638. PubMed ID: 34722271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive metabolic profiling of Parkinson's disease by liquid chromatography-mass spectrometry.
    Shao Y; Li T; Liu Z; Wang X; Xu X; Li S; Xu G; Le W
    Mol Neurodegener; 2021 Jan; 16(1):4. PubMed ID: 33485385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated Metabolomics and Proteomics Analysis Reveals Plasma Lipid Metabolic Disturbance in Patients With Parkinson's Disease.
    Hu L; Dong MX; Huang YL; Lu CQ; Qian Q; Zhang CC; Xu XM; Liu Y; Chen GH; Wei YD
    Front Mol Neurosci; 2020; 13():80. PubMed ID: 32714143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration of lipids and amino acids in plasma distinguish schizophrenia patients from controls: A targeted metabolomics study.
    Liu Y; Song X; Liu X; Pu J; Gui S; Xu S; Tian L; Zhong X; Zhao L; Wang H; Liu L; Xu G; Xie P
    Psychiatry Clin Neurosci; 2021 Apr; 75(4):138-144. PubMed ID: 33421228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the lipid biomarkers from plasma in idiopathic pulmonary fibrosis by Lipidomics.
    Yan F; Wen Z; Wang R; Luo W; Du Y; Wang W; Chen X
    BMC Pulm Med; 2017 Dec; 17(1):174. PubMed ID: 29212488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipids, Lipoproteins, and Metabolites and Risk of Myocardial Infarction and Stroke.
    Holmes MV; Millwood IY; Kartsonaki C; Hill MR; Bennett DA; Boxall R; Guo Y; Xu X; Bian Z; Hu R; Walters RG; Chen J; Ala-Korpela M; Parish S; Clarke RJ; Peto R; Collins R; Li L; Chen Z;
    J Am Coll Cardiol; 2018 Feb; 71(6):620-632. PubMed ID: 29420958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma metabolomics of children with aberrant serum lipids and inadequate micronutrient intake.
    Li KJ; Jenkins N; Luckasen G; Rao S; Ryan EP
    PLoS One; 2018; 13(10):e0205899. PubMed ID: 30379930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipidomic profiling of plasma samples from patients with mitochondrial disease.
    Ren C; Liu J; Zhou J; Liang H; Zhu Y; Wang Q; Leng Y; Zhang Z; Yuan Y; Wang Z; Yin Y
    Biochem Biophys Res Commun; 2018 Jun; 500(2):124-131. PubMed ID: 29627572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid mediators of inflammation as novel plasma biomarkers to identify patients with bacteremia.
    To KK; Lee KC; Wong SS; Lo KC; Lui YM; Jahan AS; Wu AL; Ke YH; Law CY; Sze KH; Lau SK; Woo PC; Lam CW; Yuen KY
    J Infect; 2015 May; 70(5):433-44. PubMed ID: 25727996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolite and peptide levels in plasma and CSF differentiating healthy controls from patients with newly diagnosed Parkinson's disease.
    Trupp M; Jonsson P; Ohrfelt A; Zetterberg H; Obudulu O; Malm L; Wuolikainen A; Linder J; Moritz T; Blennow K; Antti H; Forsgren L
    J Parkinsons Dis; 2014; 4(3):549-60. PubMed ID: 24927756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlations between blood lipid, serum cystatin C, and homocysteine levels in patients with Parkinson's disease.
    Li J; Gu C; Zhu M; Li D; Chen L; Zhu X
    Psychogeriatrics; 2020 Mar; 20(2):180-188. PubMed ID: 31828903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum metabolomics analysis revealed metabolic disorders in Parkinson's disease.
    Lan TT; Chang L; Hou LW; Wang ZZ; Li DC; Ren ZH; Gu T; Wang JW; Chen GS
    Medicine (Baltimore); 2023 Jun; 102(23):e33715. PubMed ID: 37335671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.